Objective To investigate the modulatory effects of Angelica Sinensis Polysaccharide (ASP) on intestinal microbiota and its subsequent influence on cerebral ischemia/reperfusion (I/R) injury in murine models. Methods A cohort of 64 SPF level mice was stratified into four groups: sham operation group (Sham group), middle cerebral artery occlusion group (MCAO group), ASP gavage group (ASP group), and fecal microbiota transplantation group (ASP-FMT group), each comprising 16 subjects. Following a 7-day regimen of the respective interventions, the MCAO model was established. Neurological function deficits were quantified 24 hours post-MCAO using the modified Neurological Severity Scores (mNSS); cerebral infarct size was assessed via 2,3,5-triphenyltetrazolium chloride (TTC) staining; concentrations of superoxide dismutase (SOD), malondialdehyde (MDA), and glutathione (GSH) in the ischemic penumbra were determined using assay kits. Additionally, the expression levels of inflammatory cytokines IL-1β, IL-5, IL-6, and IL-10 in brain tissues were quantified via Western blot, while 1 the diversity of intestinal microbiota was analyzed by 6s rRNA sequencing of cecal contents. Results Compared with the MCAO group, neurological function was markedly ameliorated after ASP intervention (P<0.001), cerebral infarct size was significantly reduced (P<0.01), and oxidative stress levels were attenuated (P<0.05). Compared with the MCAO group, the expression of pro-inflammatory cytokines IL-1β, IL-5, and IL-6 were substantially decreased by ASP intervention, while concurrently upregulated the anti-inflammatory cytokine IL-10 (P<0.05). Post-MCAO, a notable depletion in the richness of intestinal microbiota and a reduction in probiotic strains were observed. However, ASP administration or fecal microbiota transplantation partially restored microbiota richness and enhanced the proportion of probiotics. A correlation was established between the modulation of intestinal microbiota and the degree of brain tissue damage. Conclusions Angelica Sinensis Polysaccharide ameliorates intestinal microbiota, mitigates oxidative stress, modulates inflammatory cytokine profiles, and thereby attenuates neurological dysfunction and reduces infarct size following cerebral ischemia/reperfusion injury.
Key words
Cerebral ischemia/reperfusion injury /
  /
  /
Angelica Sinensis Polysaccharide /
  /
  /
Intestinal microbiota /
  /
  /
Inflammatory response
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
References
[1] Xu D, Kong T, Shao Z, et al. Orexin-A alleviates astrocytic apoptosis and inflammation via inhibiting OX1R-mediated NF-kappaB and MAPK signaling pathways in cerebral ischemia/reperfusion injury[J]. Biochim Biophys Acta Mol Basis Dis, 2021,1867(11):166230. DOI: 10.1016/j.bbadis.2021.166230.
[2] Singh V, Roth S, Llovera G, et al. Microbiota Dysbiosis Controls the Neuroinflammatory Response after Stroke[J]. J Neurosci, 2016,36(28):7428-7440. DOI: 10.1523/JNEUROSCI.1114-16.2016.
[3] Lian Z, Xu Y, Wang C, et al. Gut microbiota-derived melatonin from Puerariae Lobatae Radix-resistant starch supplementation attenuates ischemic stroke injury via a positive microbial co-occurrence pattern[J]. Pharmacol Res, 2023,190:106714. DOI: 10.1016/j.phrs.2023.106714.
[4] Zhang P, Zhang X, Huang Y, et al. Atorvastatin alleviates microglia-mediated neuroinflammation via modulating the microbial composition and the intestinal barrier function in ischemic stroke mice[J]. Free Radic Biol Med, 2021,162:104-117. DOI: 10.1016/j.freerad biomed.2020.11.032.
[5] Benakis C, Brea D, Caballero S, et al. Commensal microbiota affects ischemic stroke outcome by regulating intestinal gammadelta T cells[J]. Nat Med, 2016,22(5):516-523. DOI: 10.1038/nm.4068.
[6] 闫忠红. 当归属药用植物的本草学、亲缘关系、化学成分及药理作用相关性研究[D]. 黑龙江中医药大学, 2003.
[7] Yabuno S, Yasuhara T, Nagase T, et al. Synergistic therapeutic effects of intracerebral transplantation of human modified bone marrow-derived stromal cells (SB623) and voluntary exercise with running wheel in a rat model of ischemic stroke[J]. Stem Cell Res Ther, 2023,14(1):10. DOI: 10.1186/s13287-023-03236-4.
[8] Luo C, Chen Q, Liu B, et al. The Extracts of Angelica sinensis and Cinnamomum cassia from Oriental Medicinal Foods Regulate Inflammatory and Autophagic Pathways against Neural Injury after Ischemic Stroke[J]. Oxid Med Cell Longev, 2021,2021:9663208. DOI: 10.1155/2021/9663208.
[9] Liu X, Wu Z, Guo C, et al. Hypoxia responsive nano-drug delivery system based on angelica polysaccharide for liver cancer therapy[J]. Drug Deliv,2022,29(1):138-148. DOI: 10.1080/10717544.2021.2021 324.
[10]Hu Q, Wu C, Yu J, et al. Angelica sinensis polysaccharide improves rheumatoid arthritis by modifying the expression of intestinal Cldn5, Slit3 and Rgs18 through gut microbiota[J]. Int J Biol Macromol, 2022,209(Pt A):153-161. DOI: 10.1016/j.ijbiomac.2022.03.090.
[11]Lee S E, Lim C, Cho S. Angelica gigas root ameliorates ischaemic stroke-induced brain injury in mice by activating the PI3K/AKT/mTOR and MAPK pathways[J]. Pharm Biol, 2021,59(1):662-671. DOI: 10.1080/13880209.2021.1928241.
[12]Ni S, Yi N, Yuan H, et al. Angelica sinensis polysaccharide improves mitochondrial metabolism of osteoarthritis chondrocytes through PPARgamma/SOD2/ROS pathways[J]. Phytother Res, 2023,37(11):5394-5406. DOI: 10.1002/ptr.7979.
[13]Wen XD, Zhang YL, Yang L, et al. Angelica sinensis Polysaccharide and Astragalus membranaceus Polysaccharide Accelerate Liver Regeneration by Enhanced Glycolysis via Activation of JAK2/STAT3/HK2 Pathway[J]. Molecules, 2022,27(22). DOI: 10.3390/molecules 27227890.
[14]Kurian GA, Rajagopal R, Vedantham S, et al. The Role of Oxidative Stress in Myocardial Ischemia and Reperfusion Injury and Remodeling: Revisited[J]. Oxid Med Cell Longev, 2016,2016:1656450. DOI: 10.1155/2016/1656450.
[15]Liu W, Wang L, Liu C, et al. Edaravone Ameliorates Cerebral Ischemia-Reperfusion Injury by Downregulating Ferroptosis via the Nrf2/FPN Pathway in Rats[J]. Biol Pharm Bull, 2022, 45(9):1269-1275. DOI: 10.1248/bpb.b22-00186.
[16]Liu M, Xu Z, Wang L, et al. Cottonseed oil alleviates ischemic stroke injury by inhibiting the inflammatory activation of microglia and astrocyte[J]. J Neuroinflammation, 2020,17(1):270. DOI: 10.1186/s12974-020-01946-7.
[17]Benakis C, Simats A, Tritschler S, et al. T cells modulate the microglial response to brain ischemia[J]. Elife, 2022,11. DOI: 10.7554/eLife. 82031.
[18]Chen R, Wu P, Cai Z, et al. Puerariae Lobatae Radix with chuanxiong Rhizoma for treatment of cerebral ischemic stroke by remodeling gut microbiota to regulate the brain-gut barriers[J]. J Nutr Biochem, 2019,65:101-114. DOI: 10.1016/j.jnutbio.2018.12.004.
[19]Chen R, Xu Y, Wu P, et al. Transplantation of fecal microbiota rich in short chain fatty acids and butyric acid treat cerebral ischemic stroke by regulating gut microbiota[J]. Pharmacol Res, 2019,148:104403. DOI: 10.1016/j.phrs.2019.104403.
[20]Lee J, D'Aigle J, Atadja L, et al. Gut Microbiota-Derived Short-Chain Fatty Acids Promote Poststroke Recovery in Aged Mice[J]. Circ Res, 2020,127(4):453-465. DOI: 10.1161/CIRCRESAHA.119.316448.